CNC.NYSECentene CORP

Form 4: Centene Director Jessica Blume Acquires Shares in Open Market Transaction

Sentiment:

SEC Form 4 Filing


Centene director Jessica L. Blume purchased 250 shares of common stock at $59.48 per share on December 16, 2024.

Summary

  • Jessica L. Blume, a director at Centene Corp, acquired 250 shares of common stock on December 16, 2024, at a price of $59.48 per share.
  • The transaction was executed through an open market purchase.
  • Following the transaction, Ms. Blume directly owns 24,786 shares of Centene common stock, which includes 2,916 restricted stock units subject to vesting requirements.
  • Ms. Blume also indirectly owns 250 shares through a revocable family trust where she serves as the sole trustee.
  • Additionally, Ms. Blume holds options to purchase 20,000 shares of common stock at an exercise price of $55.29, which were granted on April 24, 2021, and expire on April 24, 2028.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction by a company director. It is neither significantly positive nor negative, but the purchase of shares can be seen as a mild positive.

Positives

  • The purchase of shares by a director can be seen as a positive sign of confidence in the company's future prospects.

Industry Context

This is a routine filing related to insider trading activity, which is common for publicly traded companies. It provides transparency into the transactions of company directors.

Comparison to Industry Standards

  • Form 4 filings are standard practice for publicly traded companies in the US, and this filing is consistent with those requirements.
  • The transaction is a relatively small open market purchase, which is not unusual for directors of large companies.
  • The stock option grants are also a common form of compensation for directors and executives.

Stakeholder Impact

  • The purchase of shares by a director may have a slightly positive impact on shareholder sentiment.

Key Dates

DateDescription
04/24/2021Date of grant for stock options.
12/16/2024Date of the open market purchase of 250 shares.
12/17/2024Date the Form 4 was signed.
04/24/2028Expiration date of the stock options.

Keywords

Centene, Director, Insider Trading, Stock Purchase, Form 4, Jessica Blume, Share Acquisition, Equity, Options

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.